European equities traded in the US as American depositary receipts were tracking significantly higher late Wednesday morning, rising 2.25% to 1,910.17 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and healthcare tech conglomerate Philips (PHG), which climbed 7.9% and 8% respectively. They were followed by lender Banco Santander (SAN) and pharmaceutical company Novo Nordisk (NVO), which increased 6.7% and 6.6%. respectively
The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and biopharmaceutical company DBV Technologies (DBVT), which lost 4.8% and 1.6%, respectively. They were followed by oil and gas company Eni (E) and biopharmaceutical company Grifols (GRFS), which dropped 1.5% and 1.4%, respectively.
The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and medical device maker Smith & Nephew (SNN), which rose 6.3% and 7.1%, respectively. They were followed by lenders Lloyds Banking Group (LYG) and HSBC (HSBC), which were up 5.5% and 5.3%, respectively.
The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and oil and gas company BP (BP), which fell 6% and 2.1%, respectively. They were followed by oil and gas company Shell (SHEL), which was off 1.2%.
Source: finance.yahoo.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.
